Search results for "Phosphodiesterase 10A"

showing 2 items of 2 documents

Phosphodiesterase 10A in the Rat Pineal Gland: Localization, Daily and Seasonal Regulation of Expression and Influence on Signal Transduction

2010

The cyclic nucleotide phosphodiesterase 10A (PDE10A) is highly expressed in striatal spiny projection neurons and represents a therapeutic target for the treatment of psychotic symptoms. As reported previously [J Biol Chem 2009; 284:7606–7622], in this study PDE10A was seen to be additionally expressed in the pineal gland where the levels of PDE10A transcript display daily changes. As with the transcript, the amount of PDE10A protein was found to be under daily and seasonal regulation. The observed cyclicity in the amount of PDE10A mRNA persists under constant darkness, is blocked by constant light and is modulated by the lighting regime. It therefore appears to be driven by the master cloc…

Malemedicine.medical_specialtyAANATPhosphodiesterase InhibitorsEndocrinology Diabetes and MetabolismBlotting WesternBiologyReal-Time Polymerase Chain ReactionPineal GlandRats Sprague-DawleyCellular and Molecular NeurosciencePineal glandEndocrinologyOrgan Culture TechniquesInternal medicinePapaverinemedicineCyclic AMPAnimalsImmunoprecipitationProtein kinase A signalingCyclic GMPDNA PrimersPhosphodiesterase 10A;Circadian system;Pineal gland;Norepinephrine;cAMP;cGMP;Arylalkylamine N-acetyltransferaseEndocrine and Autonomic SystemsSuprachiasmatic nucleusPhosphoric Diester HydrolasesPhosphodiesteraseImmunohistochemistryCircadian RhythmRatsddc:medicine.anatomical_structureEndocrinologySecond messenger systemRNAFemaleSuprachiasmatic NucleusPDE10ASeasonsSignal transductionAdrenergic alpha-AgonistsSignal Transduction
researchProduct

Fragment‐ and Negative Image‐Based Screening of Phosphodiesterase 10A Inhibitors

2019

A novel virtual screening methodology called fragment‐ and negative image‐based (F‐NiB) screening is introduced and tested experimentally using phosphodiesterase 10A (PDE10A) as a case study. Potent PDE10A‐specific small‐molecule inhibitors are actively sought after for their antipsychotic and neuroprotective effects. The F‐NiB combines features from both fragment‐based drug discovery and negative image‐based (NIB) screening methodologies to facilitate rational drug discovery. The selected structural parts of protein‐bound ligand(s) are seamlessly combined with the negative image of the target's ligand‐binding cavity. This cavity‐ and fragment‐based hybrid model, namely its shape and electr…

skitsofreniastructure-based virtual screeningseulontaParkinsonin tautivirtual screeningfragmentnegative image based (FNiB) screeningphosphodiesterase 10A (PDE10A)schizophrenianegative image based (NIB)lääkkeetParkinson’s diseaseradiometric activity assayfragment-based drug discoveryHuntingtonin tautiHuntington’s disease
researchProduct